前收市價 | 0.5500 |
開市 | 0.5500 |
買盤 | 0.0000 |
賣出價 | 0.0000 |
拍板 | 5.00 |
到期日 | 2024-08-16 |
今日波幅 | 0.5500 - 0.5500 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 無 |
After losing some value lately, a hammer chart pattern has been formed for Annexon (ANNX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Here is how Annexon, Inc. (ANNX) and Avalo Therapeutics, Inc. (AVTX) have performed compared to their sector so far this year.
Annexon (ANNX) jumps 31% after meeting the primary and key secondary endpoints with the low dose of its lead candidate, ANX005, in the phase III study for Guillain-Barre syndrome.